|
Mr. Margolis founded Aurora in October 1994. Aurora Capital Corp. was registered with the SEC and became a member of the FINRA (formerly NASD) in May 1995. Aurora Capital LLC succeeded to the business of Aurora Capital Corp. on September 16, 1998. In 2004, Jeff began expanding the firm's capabilities and founded Atypical BioCapital Management LLC (Atypical Bio(tm)) and Atypical BioVentures Fund LLC, a life science fund management company and venture fund respectively. Atypical Bio(tm) also manages a micro cap and small cap public life science portfolio for a fund-of-funds. The Atypical Bio(tm) group is an affiliate of Aurora. Prior to founding Aurora, Jeff was at D. Blech & Company Incorporated from 1992 until 1994, an investment banking firm specializing in biotechnology companies. Before joining D. Blech & Company, Mr. Margolis worked for nearly a decade for the Fundamental Brokers Group, an international affiliated group of fixed income securities brokers. His last position with the firm was chief financial officer. He holds the following securities industry registrations: (i) general securities principal (Series 24), (ii) registered representative (Series 7), (iii) state agent (Series 63), (iv) financial and operations principal (Series 27), (v) municipal securities principal (Series 54), (vi) options principal (Series 4). | 